Stroke2prevent

Curated by Signal

Products to resolve the aortic arch blind spot in peri-operative TEE

Life Sciences Technologystroke2prevent.com

Overview

Stroke2prevent is developing products to resolve the aortic arch blind spot in peri-operative transesophageal echocardiograms. They are developing, A-View, a device that is inserted into the trachea of fully anaesthetised patients. The balloon catheter is filled with saline to enable echo conduction through the trachea, thus resolving the blind spot of TEE. It has received CE mark approval and is FDA 510K listed.

Key facts

Founded: 2014
Headquarters: Zwolle, Netherlands
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Optelec
Designs assistive technology products for low vision and visual impaired
Life Sciences TechnologyBarendrecht, Netherlands
Bambi Medical
Provider of wireless vital signs monitoring device for babies
Life Sciences TechnologyEindhoven, Netherlands
EdgeLeap
Data Science company
Life Sciences TechnologyUtrecht, Netherlands

About Stroke2prevent

What does Stroke2prevent do?

Stroke2prevent is developing products to resolve the aortic arch blind spot in peri-operative transesophageal echocardiograms.

Where is Stroke2prevent headquartered?

Stroke2prevent is headquartered in Zwolle, Netherlands.

When was Stroke2prevent founded?

Stroke2prevent was founded in 2014.

Which sector is Stroke2prevent in?

Stroke2prevent operates in Life Sciences Technology.

Who are Stroke2prevent's competitors?

Companies similar to Stroke2prevent include Optelec, Bambi Medical, and EdgeLeap.